Literature DB >> 13549780

Carcinoma of the prostate: metastases, therapy and survival; a statistical analysis of five hundred cases.

L W McCREA, L KARAFIN.   

Abstract

Entities:  

Keywords:  PROSTATE/neoplasms

Mesh：

Year:  1958        PMID： 13549780

Source DB:  PubMed          Journal:  J Int Coll Surg        ISSN： 0096-557X


× No keyword cloud information.
  8 in total

1.  Large cystic intraparenchymal brain metastasis from prostate cancer.

Authors:  L I Bland; W C Welch; S H Okawara
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  [On the biological behavior of prostate carcinoma in relation to the histological type].

Authors:  G MOEBIUS; H J SCHNEIDER; P HESSE
Journal:  Z Krebsforsch       Date:  1961

3.  Clinical study on prognosis of metastatic prostate cancer based on extent of disease on pretreatment bone scintigraphy.

Authors:  H Fuse; I Mizuno; T Yokoyama; M Sakamoto; T Katayama
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

4.  Nodules on the glans penis, an unusual metastatic pattern of prostate carcinoma: case report.

Authors:  G M van den Berg; H E Menke; E Stolz
Journal:  Genitourin Med       Date:  1986-04

5.  Predictive implications of bone turnover markers after palliative treatment with (186)Re-HEDP in hormone-refractory prostate cancer patients with painful osseous metastases.

Authors:  Athanasios Zafeirakis; Georgios Papatheodorou; Athanasios Arhontakis; Athanasios Gouliamos; Lambros Vlahos; Georgios S Limouris
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

6.  Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease.

Authors:  Oliver Sartor
Journal:  Rev Urol       Date:  2004

7.  Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.

Authors:  Sergio Ricci; Giuseppe Boni; Ilaria Pastina; Dario Genovesi; Claudia Cianci; Serena Chiacchio; Cinzia Orlandini; Mariano Grosso; Abedallatif Alsharif; Aldo Chioni; Samantha Di Donato; Francesco Francesca; Cesare Selli; Domenico Rubello; Giuliano Mariani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-23       Impact factor: 10.057

8.  Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.

Authors:  T Kylmälä; T L Tammela; L Risteli; J Risteli; M Kontturi; I Elomaa
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.